Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia is a clinical trial[1].
Key Facts
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia is in the country of Brazil[2].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's instance of is recorded as clinical trial[3].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's start time is recorded as +2010-02-28T00:00:00Z[4].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's end time is recorded as +2014-01-31T00:00:00Z[5].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's sponsor is recorded as University of São Paulo[6].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's main subject is recorded as schizophrenia[7].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's number of participants is recorded as {'unit': '1', 'amount': '+20'}[8].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's title is recorded as Pilot Double Blind, Placebo Controlled and Randomized Study to Assess Electroconvulsive Therapy Efficacy as Augmenting Strategy to Clozapine in Super-refractory Schizophrenia[9].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's short name is recorded as SSURECT[10].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's ClinicalTrials.gov ID is recorded as NCT02049021[12].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[13].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's research intervention is recorded as clozapine[14].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's clinical trial phase is recorded as phase IV clinical trial[15].
- Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia's study type is recorded as interventional study[16].